{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:34Z","timestamp":1792806274936,"version":"4.5.0"},"reference-count":102,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:sec id=\"ab-nrv220007-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Trigeminal autonomic cephalalgias (TACs) comprise a unique collection of primary headache disorders characterized by moderate or severe unilateral pain, localized in in the area of distribution of the first branch of the trigeminal nerve, accompanied by cranial autonomic symptoms and signs. Most TACs are rare diseases, which hampers the possibility of performing randomized clinical trials and large studies. Therefore, knowledge of treatment efficacy must be based only on observational studies, rare disease registries, and case reports, where real-world data and evidence play an important role in health care decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nrv220007-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Chronic cluster headache is the most common of these disorders, and the literature offers some evidence from randomized clinical trials to support the use of pharmacologic and neurostimulation treatments. Galcanezumab, a monoclonal antibody targeting the calcitonin gene-related peptide, was not effective at 3 months in a randomized clinical trial but showed efficacy at 12 months in a large case series. For the other TACs (ie, paroxysmal hemicrania, hemicrania continua, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms), only case reports and case series are available to guide physicians in everyday management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nrv220007-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The accumulation of epidemiologic, pathophysiologic, natural history knowledge, and data from case series and small controlled trials, especially over the past 20 years from investigators around the world, has added to the previously limited evidence and has helped advance and inform the treatment approach to rare TACs, which can be extremely challenging for clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2022.4804","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T11:13:06Z","timestamp":1673953986000},"page":"308","source":"Crossref","is-referenced-by-count":44,"title":["Management of Trigeminal Autonomic Cephalalgias Including Chronic Cluster"],"prefix":"10.1001","volume":"80","author":[{"given":"Hans Christoph","family":"Diener","sequence":"first","affiliation":[{"name":"Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), Department of Neuroepidemiology, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"Headache Science & Neurorehabilitation Centre, IRCCS C., Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Phoenix, Arizona"},{"name":"Atria Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"nrv220007r1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","article-title":"Diagnosis, pathophysiology, and management of cluster headache.","volume":"17","author":"Hoffmann","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"nrv220007r2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40265-021-01658-z","article-title":"Drug treatment of cluster headache.","volume":"82","author":"Diener","year":"2022","journal-title":"Drugs"},{"issue":"4","key":"nrv220007r3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ncl.2019.07.001","article-title":"Trigeminal autonomic cephalalgias.","volume":"37","author":"Burish","year":"2019","journal-title":"Neurol Clin"},{"key":"nrv220007r4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2020-059577","article-title":"Recent advances in the diagnosis and management of cluster headache.","volume":"376","author":"Schindler","year":"2022","journal-title":"BMJ"},{"issue":"8","key":"nrv220007r5","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0333102419856607","article-title":"Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a meta-analysis.","volume":"39","author":"de Coo","year":"2019","journal-title":"Cephalalgia"},{"issue":"9","key":"nrv220007r6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/0333102420905321","article-title":"Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: results from 3-month double-blind treatment.","volume":"40","author":"Dodick","year":"2020","journal-title":"Cephalalgia"},{"issue":"2","key":"nrv220007r7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","article-title":"Trial of galcanezumab in prevention of episodic cluster headache.","volume":"381","author":"Goadsby","year":"2019","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"nrv220007r9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10072-020-04674-1","article-title":"Cluster headache and risk of chronic transformation.","volume":"41","author":"Giani","year":"2020","journal-title":"Neurol Sci"},{"issue":"6","key":"nrv220007r10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1468-2982.2008.01592.x","article-title":"The incidence and prevalence of cluster headache: a meta-analysis of population-based studies.","volume":"28","author":"Fischera","year":"2008","journal-title":"Cephalalgia"},{"key":"nrv220007r11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1468-2982.2007.01352.x","article-title":"Randomized, double-blind placebo-controlled trial of high-flow inhaled oxygen in acute cluster headache.","volume":"27","author":"Cohen","year":"2007","journal-title":"Cephalalgia"},{"issue":"7","key":"nrv220007r12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008042.pub3","article-title":"Triptans for acute cluster headache.","volume":"2013","author":"Law","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"nrv220007r13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/hed.2004.44.issue-5","article-title":"Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.","volume":"44","author":"Dodick","year":"2004","journal-title":"Headache"},{"issue":"4","key":"nrv220007r14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1212\/01.WNL.0000046589.45855.30","article-title":"Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.","volume":"60","author":"van Vliet","year":"2003","journal-title":"Neurology"},{"issue":"22","key":"nrv220007r15","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1001\/jama.2009.1855","article-title":"High-flow oxygen for treatment of cluster headache: a randomized trial.","volume":"302","author":"Cohen","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"nrv220007r16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10194-018-0917-4","article-title":"Oxygen treatment for cluster headache attacks at different flow rates: a double-blind, randomized, crossover study.","volume":"19","author":"Dirkx","year":"2018","journal-title":"J Headache Pain"},{"issue":"1","key":"nrv220007r17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/(ISSN)1600-0404","article-title":"Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study.","volume":"88","author":"Ekbom","year":"1993","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"nrv220007r18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1468-2982.1998.1807487.x","article-title":"Sumatriptan nasal spray (20 mg\/dose) in the acute treatment of cluster headache.","volume":"18","author":"Hardebo","year":"1998","journal-title":"Cephalalgia"},{"issue":"1","key":"nrv220007r19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/PL00007854","article-title":"Treatment of acute cluster headache with 20 mg sumatriptan nasal spray: an open pilot study.","volume":"249","author":"Schuh-Hofer","year":"2002","journal-title":"J Neurol"},{"issue":"11","key":"nrv220007r20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archneur.63.11.nct60002","article-title":"Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.","volume":"63","author":"Cittadini","year":"2006","journal-title":"Arch Neurol"},{"issue":"9","key":"nrv220007r21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/01.wnl.0000267886.85210.37","article-title":"Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.","volume":"69","author":"Rapoport","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"nrv220007r22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/hed.2009.49.issue-9","article-title":"Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.","volume":"49","author":"Hedlund","year":"2009","journal-title":"Headache"},{"issue":"8","key":"nrv220007r23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/head.2016.56.issue-8","article-title":"Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study.","volume":"56","author":"Silberstein","year":"2016","journal-title":"Headache"},{"issue":"5","key":"nrv220007r24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/0333102417744362","article-title":"Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study.","volume":"38","author":"Goadsby","year":"2018","journal-title":"Cephalalgia"},{"issue":"10","key":"nrv220007r25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/0333102412473667","article-title":"Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment: pathway CH-1: a randomized, sham-controlled study.","volume":"33","author":"Schoenen","year":"2013","journal-title":"Cephalalgia"},{"issue":"12","key":"nrv220007r26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1474-4422(19)30322-9","article-title":"Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.","volume":"18","author":"Goadsby","year":"2019","journal-title":"Lancet Neurol"},{"issue":"7","key":"nrv220007r27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/hed.2010.50.issue-7","article-title":"Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches.","volume":"50","author":"Ansarinia","year":"2010","journal-title":"Headache"},{"issue":"5","key":"nrv220007r28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0333102416649092","article-title":"Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache.","volume":"37","author":"J\u00fcrgens","year":"2017","journal-title":"Cephalalgia"},{"issue":"1","key":"nrv220007r29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-017-0828-9","article-title":"Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry.","volume":"19","author":"Barloese","year":"2018","journal-title":"J Headache Pain"},{"issue":"13","key":"nrv220007r30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1177\/0333102414530524","article-title":"Stimulation of the sphenopalatine ganglion in intractable cluster headache: expert consensus on patient selection and standards of care.","volume":"34","author":"J\u00fcrgens","year":"2014","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv220007r31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(20)30023-5","article-title":"The need for continued care after sponsor closure.","volume":"19","author":"May","year":"2020","journal-title":"Lancet Neurol"},{"issue":"3","key":"nrv220007r32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/hed.1989.29.issue-3","article-title":"Prophylactic treatment of cluster headache with verapamil.","volume":"29","author":"Gabai","year":"1989","journal-title":"Headache"},{"issue":"10","key":"nrv220007r33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/hed.2004.44.issue-10","article-title":"Individualizing treatment with verapamil for cluster headache patients.","volume":"44","author":"Blau","year":"2004","journal-title":"Headache"},{"issue":"5","key":"nrv220007r34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/0333102420970455","article-title":"Real-life treatment of cluster headache in a tertiary headache center: results from the Danish Cluster Headache Survey.","volume":"41","author":"Petersen","year":"2021","journal-title":"Cephalalgia"},{"key":"nrv220007r35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1468-2982.1995.015003230.x","article-title":"Treatment of cluster headache: clinical trials, design and results.","volume":"15","author":"Ekbom","year":"1995","journal-title":"Cephalalgia"},{"issue":"8","key":"nrv220007r36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1046\/j.1526-4610.2002.02183.x","article-title":"Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.","volume":"42","author":"Mathew","year":"2002","journal-title":"Headache"},{"issue":"7","key":"nrv220007r37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1046\/j.1526-4610.2003.03137.x","article-title":"Topiramate in the prophylactic treatment of cluster headache.","volume":"43","author":"L\u00e1inez","year":"2003","journal-title":"Headache"},{"issue":"10","key":"nrv220007r38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1046\/j.1468-2982.2003.00665.x","article-title":"Topiramate in cluster headache prophylaxis: an open trial.","volume":"23","author":"Leone","year":"2003","journal-title":"Cephalalgia"},{"issue":"2","key":"nrv220007r39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0028-3886.63784","article-title":"Topiramate in prevention of cluster headache in the Taiwanese.","volume":"58","author":"Huang","year":"2010","journal-title":"Neurol India"},{"issue":"7","key":"nrv220007r40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1046\/j.1468-2982.2001.00260.x","article-title":"Drug-resistant cluster headache responding to gabapentin: a pilot study.","volume":"21","author":"Leandri","year":"2001","journal-title":"Cephalalgia"},{"issue":"6","key":"nrv220007r41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/ene.2007.14.issue-6","article-title":"The use of gabapentin in chronic cluster headache patients refractory to first-line therapy.","volume":"14","author":"Schuh-Hofer","year":"2007","journal-title":"Eur J Neurol"},{"issue":"7","key":"nrv220007r42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1468-2982.1996.1607494.x","article-title":"Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups.","volume":"16","author":"Leone","year":"1996","journal-title":"Cephalalgia"},{"issue":"8","key":"nrv220007r43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1526-4610.2002.02181.x","article-title":"Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study.","volume":"42","author":"Pringsheim","year":"2002","journal-title":"Headache"},{"issue":"11-12","key":"nrv220007r44","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/03331024221103509","article-title":"Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.","volume":"42","author":"Riesenberg","year":"2022","journal-title":"Cephalalgia"},{"issue":"7","key":"nrv220007r45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1474-4422(21)00101-0","article-title":"Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial.","volume":"20","author":"Wilbrink","year":"2021","journal-title":"Lancet Neurol"},{"key":"nrv220007r46","doi-asserted-by":"publisher","DOI":"10.3171\/2019.11.JNS192042","article-title":"Occipital nerve stimulation and deep brain stimulation for refractory cluster headache: a prospective analysis of efficacy over time.","author":"Aibar-Dur\u00e1n","journal-title":"J Neurosurg"},{"issue":"2","key":"nrv220007r47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/ene.2017.24.issue-2","article-title":"Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients.","volume":"24","author":"Miller","year":"2017","journal-title":"Eur J Neurol"},{"issue":"2","key":"nrv220007r48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/neuros\/nyaa373","article-title":"Long-term efficacy of occipital nerve stimulation for medically intractable cluster headache.","volume":"88","author":"Leplus","year":"2021","journal-title":"Neurosurgery"},{"issue":"10","key":"nrv220007r49","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/0333102411412086","article-title":"Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation.","volume":"31","author":"Fontaine","year":"2011","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv220007r50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s40122-022-00401-0","article-title":"Long-term follow-up safety and effectiveness of CT-guided radiofrequency thermocoagulation of sphenopalatine ganglion in refractory headache treatment.","volume":"11","author":"Xin","year":"2022","journal-title":"Pain Ther"},{"issue":"6","key":"nrv220007r51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0333102415607070","article-title":"Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study.","volume":"36","author":"Gaul","year":"2016","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv220007r52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/head.v62.3","article-title":"Effects of acute and preventive therapies for episodic and chronic cluster headache: a scoping review of the literature.","volume":"62","author":"Medrea","year":"2022","journal-title":"Headache"},{"issue":"3","key":"nrv220007r53","first-page":"1631","article-title":"Systematic literature review and Bayesian network meta-analysis of episodic cluster headache drugs.","volume":"25","author":"Pompilio","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"nrv220007r54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1046\/j.1468-2982.1997.1706673.x","article-title":"Double-blind placebo-controlled trial of lithium in episodic cluster headache.","volume":"17","author":"Steiner","year":"1997","journal-title":"Cephalalgia"},{"issue":"Pt 3","key":"nrv220007r55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache: neuropeptide changes and effects of acute attacks therapies.","volume":"117","author":"Goadsby","year":"1994","journal-title":"Brain"},{"issue":"1","key":"nrv220007r56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/head.v62.1","article-title":"Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.","volume":"62","author":"L\u00e1inez","year":"2022","journal-title":"Headache"},{"issue":"1","key":"nrv220007r57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ane.2019.139.issue-1","article-title":"Neurostimulation for the treatment of chronic migraine and cluster headache.","volume":"139","author":"Vukovic Cvetkovic","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"nrv220007r58","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/hed.2011.51.issue-8","article-title":"Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache.","volume":"51","author":"Magis","year":"2011","journal-title":"Headache"},{"issue":"16","key":"nrv220007r59","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1177\/0333102413493193","article-title":"Occipital nerve stimulation for intractable chronic cluster headache or migraine: a critical analysis of direct treatment costs and complications.","volume":"33","author":"Mueller","year":"2013","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv220007r60","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s10143-021-01725-9","article-title":"Gamma knife radiosurgery for the treatment of cluster headache: a systematic review.","volume":"45","author":"Franzini","year":"2022","journal-title":"Neurosurg Rev"},{"issue":"10","key":"nrv220007r61","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1474-4422(06)70575-0","article-title":"Deep brain stimulation in headache.","volume":"5","author":"Leone","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"nrv220007r62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11916-022-01025-x","article-title":"Neuromodulation for chronic daily headache.","volume":"26","author":"Coppola","year":"2022","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"nrv220007r63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/head.v62.4","article-title":"Challenges and complexities in designing cluster headache prevention clinical trials: a narrative review.","volume":"62","author":"Dodick","year":"2022","journal-title":"Headache"},{"issue":"3","key":"nrv220007r64","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/head.v60.3","article-title":"Episodic and chronic cluster headache: differences in family history, traumatic head injury, and chronorisk.","volume":"60","author":"Barloese","year":"2020","journal-title":"Headache"},{"issue":"10","key":"nrv220007r65","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/head.v60.10","article-title":"Ketamine-magnesium for refractory chronic cluster headache: a case series.","volume":"60","author":"Moisset","year":"2020","journal-title":"Headache"},{"issue":"1","key":"nrv220007r66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s10194-018-0874-y","article-title":"OnabotulinumtoxinA in the treatment of refractory chronic cluster headache.","volume":"19","author":"Lampl","year":"2018","journal-title":"J Headache Pain"},{"issue":"8","key":"nrv220007r67","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10072-016-2560-7","article-title":"Can paroxysmal hemicrania be bilateral? a case report.","volume":"37","author":"Degirmenci","year":"2016","journal-title":"Neurol Sci"},{"issue":"9","key":"nrv220007r68","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1046\/j.1468-2982.2001.00287.x","article-title":"Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua.","volume":"21","author":"Pareja","year":"2001","journal-title":"Cephalalgia"},{"issue":"pt 4","key":"nrv220007r69","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/brain\/awn010","article-title":"Paroxysmal hemicrania: a prospective clinical study of 31 cases.","volume":"131","author":"Cittadini","year":"2008","journal-title":"Brain"},{"issue":"1","key":"nrv220007r70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1129-2377-14-26","article-title":"Paroxysmal hemicrania: a retrospective study of a consecutive series of 22 patients and a critical analysis of the diagnostic criteria.","volume":"14","author":"Prakash","year":"2013","journal-title":"J Headache Pain"},{"issue":"8","key":"nrv220007r71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1526-4610.2002.02171.x","article-title":"Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients.","volume":"42","author":"Boes","year":"2002","journal-title":"Headache"},{"issue":"2","key":"nrv220007r72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/children8020101","article-title":"Long-term outcome of indomethacin treatment in pediatric patients with paroxysmal hemicrania: a case series.","volume":"8","author":"Mauritz","year":"2021","journal-title":"Children (Basel)"},{"issue":"1","key":"nrv220007r73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-017-0777-3","article-title":"Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.","volume":"18","author":"Baraldi","year":"2017","journal-title":"J Headache Pain"},{"issue":"9","key":"nrv220007r74","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/jnnp-2018-319538","article-title":"Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania.","volume":"90","author":"Kamourieh","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"nrv220007r75","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamaneurol.2017.2122","article-title":"Noninvasive vagus nerve stimulation for treatment of indomethacin-sensitive headaches.","volume":"74","author":"Tso","year":"2017","journal-title":"JAMA Neurol"},{"key":"nrv220007r76","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2147\/JPR","article-title":"Hemicrania continua: clinical review, diagnosis and management.","volume":"10","author":"Prakash","year":"2017","journal-title":"J Pain Res"},{"issue":"3","key":"nrv220007r77","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/head.2015.55.issue-3","article-title":"How effective is melatonin as a preventive treatment for hemicrania continua? a clinic-based study.","volume":"55","author":"Rozen","year":"2015","journal-title":"Headache"},{"key":"nrv220007r78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10194-015-0502-z","article-title":"OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients.","volume":"16","author":"Miller","year":"2015","journal-title":"J Headache Pain"},{"key":"nrv220007r79","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417731349","article-title":"Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: a real-world experience.","volume":"333102417731349","author":"Trimboli","year":"2017","journal-title":"Cephalalgia"},{"issue":"2","key":"nrv220007r80","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11916-010-0098-6","article-title":"Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias.","volume":"14","author":"Marmura","year":"2010","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"nrv220007r81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jnnp-2020-323999","article-title":"Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis.","volume":"92","author":"Lambru","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"nrv220007r82","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1177\/0333102417739304","article-title":"Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial.","volume":"38","author":"Weng","year":"2018","journal-title":"Cephalalgia"},{"issue":"Pt 10","key":"nrv220007r83","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/brain\/aww204","article-title":"Ventral tegmental area deep brain stimulation in refractory short-lasting unilateral neuralgiform headache attacks.","volume":"139","author":"Miller","year":"2016","journal-title":"Brain"},{"issue":"5","key":"nrv220007r84","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1177\/0333102417721716","article-title":"Long-term follow up of intractable chronic short lasting unilateral neuralgiform headache disorders treated with occipital nerve stimulation.","volume":"38","author":"Miller","year":"2018","journal-title":"Cephalalgia"},{"issue":"8","key":"nrv220007r85","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/brain\/awac109","article-title":"Trigeminal microvascular decompression for short-lasting unilateral neuralgiform headache attacks.","volume":"145","author":"Lambru","year":"2022","journal-title":"Brain"},{"issue":"10","key":"nrv220007r86","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/head.13187","article-title":"Occipital nerve stimulation for medically refractory chronic paroxysmal hemicrania.","volume":"57","author":"Miller","year":"2017","journal-title":"Headache"},{"issue":"Pt 7","key":"nrv220007r87","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/brain\/awq137","article-title":"Hemicrania continua: a clinical study of 39 patients with diagnostic implications.","volume":"133","author":"Cittadini","year":"2010","journal-title":"Brain"},{"issue":"12","key":"nrv220007r88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11910-018-0899-2","article-title":"Hemicrania continua: a clinical perspective on diagnosis and management.","volume":"18","author":"Mehta","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"nrv220007r89","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0333102412452043","article-title":"A proposal for revision of hemicrania continua diagnostic criteria based on critical analysis of 62 patients.","volume":"32","author":"Prakash","year":"2012","journal-title":"Cephalalgia"},{"issue":"3","key":"nrv220007r90","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1468-2982.2009.01910.x","article-title":"Delayed response of indomethacin in patients with hemicrania continua: real or phantom headache?","volume":"30","author":"Prakash","year":"2010","journal-title":"Cephalalgia"},{"issue":"2","key":"nrv220007r91","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/j.pain.0000000000002032","article-title":"Differential actions of indomethacin: clinical relevance in headache.","volume":"162","author":"Summ","year":"2021","journal-title":"Pain"},{"issue":"4","key":"nrv220007r92","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10072-014-2036-6","article-title":"Hemicrania continua with visual aura successfully treated with a combination of indomethacin and topiramate.","volume":"36","author":"Fantini","year":"2015","journal-title":"Neurol Sci"},{"issue":"3","key":"nrv220007r93","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/head.2019.59.issue-3","article-title":"Topiramate as an indomethacin-sparing agent in hemicrania continua: a report of 2 cases.","volume":"59","author":"Prakash","year":"2019","journal-title":"Headache"},{"issue":"6","key":"nrv220007r94","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/0333102412439800","article-title":"Peripheral nerve blocks: a therapeutic alternative for hemicrania continua.","volume":"32","author":"Guerrero","year":"2012","journal-title":"Cephalalgia"},{"issue":"9","key":"nrv220007r95","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/jnnp-2017-315747","article-title":"Treatment of intractable hemicrania continua by occipital nerve stimulation.","volume":"88","author":"Miller","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"nrv220007r96","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S1474-4422(08)70217-5","article-title":"Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study.","volume":"7","author":"Burns","year":"2008","journal-title":"Lancet Neurol"},{"issue":"Pt 10","key":"nrv220007r97","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/brain\/awl202","article-title":"Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA.","volume":"129","author":"Cohen","year":"2006","journal-title":"Brain"},{"issue":"3","key":"nrv220007r98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/WCO.0000000000000090","article-title":"SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder?","volume":"27","author":"Lambru","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"nrv220007r99","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jocn.2006.09.006","article-title":"SUNCT and SUNA: clinical features and medical treatment.","volume":"15","author":"Williams","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"1","key":"nrv220007r100","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5505\/agri.2016.25991","article-title":"Peripheral nerve blocks for the treatment of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) during pregnancy.","volume":"30","author":"Yalin","year":"2018","journal-title":"Agri"},{"issue":"2","key":"nrv220007r101","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/0333102417735847","article-title":"Microvascular decompression or neuromodulation in patients with SUNCT and trigeminal neurovascular conflict?","volume":"38","author":"Hassan","year":"2018","journal-title":"Cephalalgia"},{"issue":"5","key":"nrv220007r102","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/head.v60.5","article-title":"Sphenopalatine ganglion pulsed radiofrequency for the treatment of refractory chronic SUNCT and SUNA: a prospective case series.","volume":"60","author":"Ornello","year":"2020","journal-title":"Headache"},{"key":"nrv220007r8","first-page":"1","volume-title":"Cephalalgia","year":"2018"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2800166\/jamaneurology_diener_2023_rv_220007_1677854360.36406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T11:09:59Z","timestamp":1678705799000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2800166"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.4804","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}